3,5-diisopropylsalicylic acid has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrich, D; Li, D; Li, L; Lin, MH; Suhrbier, A; Tang, B | 1 |
| Hein, MD; Kupke, SY; Marichal-Gallardo, P; Marsall, P; Pelz, L; Piagnani, E; Reichl, U; Wynserski, N | 1 |
2 other study(ies) available for 3,5-diisopropylsalicylic acid and Congenital Zika Syndrome
| Article | Year |
|---|---|
Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Topics: Animals; Antiviral Agents; COVID-19; Defective Interfering Viruses; Dengue; Dengue Virus; Humans; Interferon Type I; SARS-CoV-2; Yellow Fever; Yellow fever virus; Zika Virus; Zika Virus Infection | 2022 |
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coinfection; Defective Interfering Viruses; Humans; Influenza A virus; Influenza, Human; Vero Cells; Virus Replication; Yellow Fever; Zika Virus; Zika Virus Infection | 2023 |